Literature DB >> 14652717

Recurrence of Budd-Chiari syndrome after liver transplantation in paroxysmal nocturnal hemoglobinuria.

Matthias J Bahr1, Jörg Schubert, Jörg S Bleck, Uwe J F Tietge, Bita Boozari, Reinhold E Schmidt, Jürgen Klempnauer, Christian P Strassburg, Michael P Manns.   

Abstract

Venous thrombembolism is a major complication of paroxysmal nocturnal hemoglobinuria (PNH). Often, veins of atypical localization are afflicted, resulting in cerebral, mesenteric, or hepatic venous thrombosis. We present a patient who received an orthotopic liver graft for chronic Budd-Chiari syndrome in 1988. PNH was the only thrombophilic predisposition identified in this patient. After transplantation, he repeatedly suffered from hemorrhage. Subsequently, the patient discontinued prophylactic anticoagulation nearly 10 years after transplantation. Within 6 months Budd-Chiari syndrome recurred, but stabilized after anticoagulation therapy with low-molecular-weight heparin was reinstituted. The patient is clinically stable 14 years after receiving the liver graft. Eleven cases of relapsing Budd-Chiari syndrome have been reported in the literature. Of these, four patients suffered from PNH. All patients transplanted for PNH-associated Budd-Chiari syndrome in these reports suffered from either major bleeding or thrombosis. In conclusion, patients afflicted with PNH appear to be at high risk of incurring complications after liver transplantation.

Entities:  

Mesh:

Year:  2003        PMID: 14652717     DOI: 10.1007/s00147-003-0636-9

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  2 in total

Review 1.  Management of thrombosis in paroxysmal nocturnal hemoglobinuria: a clinician's guide.

Authors:  Morag Griffin; Talha Munir
Journal:  Ther Adv Hematol       Date:  2016-12-21

2.  Successful Treatment of Ascites using a Denver® Peritoneovenous Shunt in a Patient with Paroxysmal Nocturnal Hemoglobinuria and Budd-Chiari syndrome.

Authors:  Tomomi Kogiso; Etsuko Hashimoto; Taito Ito; Toshifumi Hara; Yuichi Ikarashi; Kazuhisa Kodama; Makiko Taniai; Nobuyuki Torii; Kentaro Yoshinaga; Satoru Morita; Yutaka Takahashi; Junji Tanaka; Shuji Sakai; Masakazu Yamamoto; Katsutoshi Tokushige
Journal:  Intern Med       Date:  2016-10-15       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.